Faes Farma (FRA:FFEA) Beta: 0.7154 (As of Jun. 28, 2026)


FRA:FFEA Faes Farma SA FRA:FFEA
90 GF Score
Price €4.54
GF Value €5.02
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Faes Farma Beta?

Faes Farma FRA:FFEA -0.44% 90 Beta is 0.7154 as of Jun. 28, 2026. GuruFocus rates FRA:FFEA with a GF Score™ of 90/100 and a GF Value™ of €5.02 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Faes Farma's Beta is 0.7154.


Faes Farma  (FRA:FFEA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Faes Farma Beta Related Terms


Faes Farma Beta Historical Data

* Premium members only.

The historical data trend for Faes Farma's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma Beta Chart

Faes Farma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.84 0.50 0.59 -0.30

Faes Farma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.67 0.59 0.65 -0.30

FRA:FFEA vs ZTS, UTHR, VTRS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Beta distribution charts can be found below:

* The bar in red indicates where Faes Farma's Beta falls into.


FRA:FFEA
90GF Score
Faes Farma SA FRA:FFEA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faes Farma Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7154 mean?
Faes Farma (FRA:FFEA) has a Beta of 0.7154 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Faes Farma and its competitors.
Is Faes Farma's Beta too high?
Faes Farma's current Beta is 0.7154. Overall, Faes Farma has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Beta compare to ZTS and UTHR?
Faes Farma's Beta of 0.7154 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Faes Farma and its competitors. Faes Farma's current Beta is 0.7154. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.02, compared to a current price of €4.54 — trading 9.7% below its estimated fair value. The current Beta is 0.7154. Faes Farma's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Beta is 0.7154 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Faes Farma (FRA:FFEA) Overvalued in 2026?

Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued. The current stock price of €4.54 is trading 9.7% below its estimated GF Value™ of €5.02. GuruFocus considers Faes Farma to be Modestly Undervalued.

Key valuation signals for FRA:FFEA:

  • Beta: 0.7154
  • GF Value™: €5.02 vs. price of €4.54 (9.7% below fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Faes Farma Business Description

Other Exchanges 0K9H:UKFAE:Spain
Address Avenida Autonomia, 10, Leioa, Vizcaya, ESP, 48940
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
90GF Score

Get the complete analysis for FRA:FFEA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.54
Price
€5.02
GF Value